Answers are grounded in this paper and cite their sources.
Systematic review and meta-analysis reveal sustained antidepressant effects of DBS in treatment-resistant depression.
Abstract A significant proportion of patients with major depressive disorder (MDD) experience treatment-resistant depression (TRD). Deep brain stimulation (DBS) is a surgical intervention under investigation for TRD which has shown promise in some settings but inconsistent outcomes overall. We conducted a random-effects meta-analysis of open-label and randomized controlled trials to provide an up-to-date assessment of DBS efficacy in TRD. Depressive symptoms improved across short-term (6–9 months), moderate-term (12–24 months), and long-term (>24 months) time points after DBS initiation, with effect sizes (Hedges’ g) of 2.40, 2.83, and 4.33, respectively. Neither study design nor stimulation target significantly influenced outcomes, although subcallosal cingulate stimulation was generally associated with more pronounced effects. Furthermore, higher follow-up frequency correlated positively with rate of symptom improvement. Our findings support that DBS can exert sustained antidepressant effects, and provide insights that can be used to better establish its efficacy vs. placebo and optimize its clinical implementation.
No takes yet. Share an insight, caveat, or question.
Davidson et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: